The lawsuit, filed in the United States District Court for the Eastern District of Pennsylvania, stems from a sharp decline in Datavault AI (NASDAQ: DVLT) stock on October 31, 2025. Shares dropped 19.44%—a loss of $0.49—after a Wolfpack Research report challenged the commercial substance of several high-profile initiatives. The complaint alleges that the company touted partnerships with Burke Products, Scilex Holding Company, and Nature's Miracle despite evidence suggesting the counterparties lacked the financial capacity to fulfill their commitments.
Beyond the partnership disputes, the legal action highlights concerns over the company's internal transparency. Shareholders allege that Datavault AI failed to disclose critical regulatory and criminal histories involving its leadership and patent co-inventors. Furthermore, the suit claims that trading activity on the firm's platform was minimal, consisting largely of widely available public data rather than the proprietary value promised to investors. During the specified Class Period, company insiders reportedly sold over 38 million shares, generating more than $73.8 million in proceeds, before the market correction triggered by the research report.

Comments (0)
No comments yet. Be the first!